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Analysis of diclofenac in water samples using in situ 
derivatization-vortex-assisted liquid-liquid microextraction 
with gas chromatography-mass spectrometry
A novel micro-extraction technique for a rapid and sensi-
tive analysis of diclofenac (DCF) in water samples has been 
developed. DCF was derivatized and extracted simultane-
ously using vortex-assisted liquid-liquid micro-extraction 
(VALLME) prior to gas chromatography with mass spec-
trometry detection. The effects of extraction solvent vol-
ume, extraction and derivatization time and ionic strength 
of the sample were studied using 23 factorial experimental 
design. The optimum extraction conditions were as fol-
lows: 200 µL of chloroform, 25 µL of N-methyl-N-trimethyl-
silyl-trifluoroacetamide (MSTFA) derivatization reagent, 
vortex extraction and derivatization time 5 min at 3000 
rpm. The extraction recovery for different fortification levels 
was 98 %. Also, the proposed micro-extraction method 
 exhibited results comparable with the solid phase extrac-
tion of real water samples. The proposed one-step VALLME 
and derivatization method is simpler and faster than the 
conventional extraction and derivatization methods used 
for the determination of DCF in real water samples. 
Keywords: diclofenac, GC-MS, in situ derivatization, vortex-
assisted liquid-liquid micro-extraction, water
Pharmaceutical compounds (PhCs) in water have become a major concern for human 
health and the environment because PhCs are often resistant to biodegradation in aquatic 
and terrestrial ecosystems. In recent years, determination of pharmaceuticals in different 
environmental media has become a relevant topic. The most important source of PhCs in 
an aquatic environment is urban wastewater. After being used, these compounds are ex-
creted into the sewerage system. Also, unused or expired drugs are at the disposal to the 
sewerage system. Conventional wastewater treatment plants (WWTP) do not provide for 
the removal of PhCs (1, 2). Diclofenac (DCF, C14H11Cl2NO2, Mr 296.16, pKa 4.15, log Kow 4.51) 
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is a nonsteroidal anti-inflammatory drug (NSAID). It is one of the mostly detected PhCs in 
the environment because it is not effectively removed by the current conventional WWT 
processes. In the literature, different removal rates for DCF have been determined, such as 
0 % (3), 17 % (4), 69 % (5), 100 % (6) in wastewater treatment plants. Recent studies have 
indicated that DCF has been detected in groundwater, some drinking water, surface water, 
seawater, wastewater, WWTP effluents and in sludge in many countries at concentrations 
generally in the ng L–1 to µg/L range. The maximum concentration of DCF of 3.5 µg L–1 has 
been detected in effluent wastewaters at five different sewage treatment plants in Spain (7). 
Up to 717 ng L–1 DCF was determined in surface water in China (8). In Mexico City, 1 and 
20-32 ng L–1 DCF, resp., has been reported in groundwater and in surface water (9). In 
river and pond waters in Germany DCF has been measured in 10 out of 27 water samples 
in concentrations of up to 15 µg L–1 (10). DCF has also been detected up to a concentration 
of 380 ng L–1 in the groundwater of Barcelona (11). Extensive and continuous release of DCF 
from domestic and hospital wastewaters is a potential risk to non-target organisms, even 
at concentrations of ≤ 1 µg L–1 (12). According to the results of toxicity tests, DCF exhibited 
the highest acute toxicity within the class of NSAIDs. DCF is listed among priority sub-
stances in the European Union Water Framework Directive (2000/60/EC). Recently, DCF 
was included in the watch list in Directive 2013/39/EU and is monitored by the EU member 
states in water media.
DCF in aqueous samples can be determined by chromatographic techniques, i.e., high 
performance liquid chromatography (HPLC) coupled with mass spectrometry (MS), tan-
dem mass spectrometry (MS-MS), fluorescence (FL) or ultraviolet detection (UV), or gas 
chromatography (GC) coupled with MS and MS-MS after sample pre-concentration steps 
such as solid phase extraction (SPE). DCF should be derivatized prior to GC analysis. SPE 
was generally used for determination of DCF in water samples (13). However, there are 
some disadvantages of SPE methods; analytes may be adsorbed and complex matrices can 
cause settling in cartridges. The SPE method requires a disposable cartridge with a mani-
fold system and a large volume of organic solvents (14). In recent years, for extraction and 
pre-concentration of DCF residues in water, several micro-extraction based methods have 
been developed, including solid-phase micro-extraction (SPME) (15), stir bar sorptive ex-
traction (SBSE) (16), fiber liquid-phase micro-extraction (HF-LPME) (17), ultrasound-assisted 
emulsification micro-extraction (USAEME) (18), sonication-assisted emulsification micro-
extraction combined with vortex assisted porous membrane protected micro-solid-phase 
extraction (SAEME-VA-µ-SPE) (19), dispersive liquid-liquid micro-extraction and single-
drop micro-extraction (20). However, these techniques have some drawbacks. For instance, 
the SPME method has a high price and fiber fragility, as well as carryover problems. LPME, 
SDME and DLLME methods are complex and difficult for automation. These methods also 
suffer from droplet instability and relatively low precision. The ultrasound energy used in 
the USAEME method may degrade the analytes and can lead to low recovery. There is 
recently a growing interest in simultaneous micro-extraction and derivatization methods.
In this study, a novel analytical method for determining the residues of DCF in waters 
was developed by VALLME with in situ derivatization followed by GC-MS. Chang et al. (21) 
employed this method successfully for determination of aliphatic amines. Thus far, 
VALLME with in situ derivatization has not been used for the residue analysis of DCF in 
water samples.
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DCF sodium was purchased from Fluka (Switzerland). N-methyl-N-trimethylsilyl-
trifluoroacetamide (MSTFA) was purchased from Merck (Germany). Sodium chloride and 
all organic solvents were also purchased from Merck. Deionized water was prepared 
with the aid of a Millipore Milli-Q Plus water purification system (Millipore, USA). Stock 
solutions of DCF were prepared in methanol. Working solutions were prepared by diluting 
the standard stock solution with deionized water and storing it in the dark at 4 °C until use.
Real water samples
Tap water was obtained from the laboratory. Bottled water was taken from the market 
in Konya, Turkey. The surface water sample was collected from the Altınapa dam in Konya. 
Wastewater influent and effluent samples were taken from domestic WWTP from Konya. 
One-L amber glass bottles were used for sample collection. All samples were collected on 
the day before being analyzed. Sample bottles were rinsed with the sample prior to sample 
collection. Dam and wastewater samples were filtered using membrane filters (Sartorius, 
Germany) before the extraction.
Instrumentation
Quantification of DCF was carried out using a gas chromatograph equipped with a 
quadrupole mass selective detector with electron ionization and a programmed tempera-
ture vaporizing (PTV) injector (Agilent Technologies, USA). DB-5 MS capillary column (30 
m length, 0.25 mm i.d. and 0.25 µm film thickness) was used for separation. The oven 
program was as follows: initial temperature 80 °C for 1 min, 15 °C min–1 to 300 °C, hold at 
300 °C for 2 min (run time: 17.67 min). Helium was used as carrier gas at a constant flow-
rate of 1.9 mL min–1. PTV was operated in splitless mode. One µL injection was applied 
with an Agilent 7683 B Series automatic injector. The temperature of the ion source was 150 
°C while MS transfer line was at 270 °C. MS detector operated in the selected ion monitoring 
(SIM) mode. Ions at m/z 214, 242 and 277 were monitored. Quantitation was based on the 
ion at m/z 214 monitoring.
A vortex agitator (Wiggen Hauser, Germany) was used for the extraction and deriva-
tization process.
A 100-µL Hamilton syringe (Hamilton Bonaduz AG, Switzerland) was used to intro-
duce the organic solvent into the aqueous sample.
VALLME with in situ derivatization
To determine VALLME efficiency with in situ derivatization, spiking experiments 
were carried out. Firstly, some factors affecting the extraction process such as solvent type 
(dichloromethane, chloroform, 1,2-dichlorobenzene, bromoform, n-hexane, cyclohexane, 
petroleum ether, 2-propanol, isooctane, n-pentane, toluene, diethylether, methanol, and 
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ethyl acetate), derivatization reagent volume (25–200 µL) and the vortex agitation speed 
(0–3000 rpm) were tested. Then, 23 factorial experimental design was applied for simulta-
neous optimization of the extraction solvent volume, extraction and derivatization time, 
and ionic strength of the sample. To determine extraction efficiency of different solvents, 5 
mL of an aqueous standard solution containing 5 µg L–1 DCF was placed in a 10-mL Falcon 
tube. A hundred µL of derivatization reagent (MSTFA) and 100 µL of extraction solvent 
were injected into the tube. Then, the tube was strongly vortex shaken for 2 min at 1200 
rpm. As a result, DCF derivatized with MSTFA was extracted from the aqueous bulk to the 
organic phase. After that, the mixture was centrifuged for 5 min at 4000 rpm and the 
lower organic phase was removed using a 100-µL syringe and put into the glass micro-
vial for analysis. Extraction solvent volume, extraction and derivatization time, and ionic 
strength of the sample (addition of NaCl into the sample), were termed factors 1, 2 and 3, 
resp. The experiments were randomly carried out (in duplicate) to avoid any systematic 
error. Low and high levels for factors 1, 2 and 3 were selected as 100 and 200 µL, 2 and 5 
min, 0 and 0.05 g mL–1, resp. The experimental matrix design is given in Table I.
Table I. Factorial matrix
Experiment 
No.

























































Factor 1: solvent volume (µL); factor 2: extraction and derivatization time (min); factor 3: ionic strength of the 
sample (g L–1). –/+: denoting lower/upper factor level.
Solid phase extraction (SPE)
An oasis HLB cartridge (Waters, USA) was used for SPE extraction of DCF from water 
samples. Traditional SPE procedure was performed according to the US EPA method for 
DCF extraction (22). Five mL of de-ionized water following 5 mL of methanol were used to 
condition the cartridge. The water sample (200 mL) was passed and the cartridge was dried 
for 10 min under vacuum. After extraction, elution of the DCF from the cartridge was 
performed with 10 mL of methanol. Derivatization with MSTFA was performed prior to 
GC analysis. After 200 µL of MSTFA and 5 µL of pyridine were added into the 1-mL extract, 
it was incubated for 30 min at 80 °C and then cooled to room temperature.
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RESULTS AND DISCUSSION
Optimization of extraction parameters: solvent type, derivatization reagent volume and 
agitation speed
Selection of an appropriate extraction solvent is very important for efficient extraction 
in the VALLME procedure. It should meet some criteria. For example, it must be immiscible 
with water, with excellent gas chromatographic behavior and high affinity to analytes (23). 
Fig. 1. Recovery of DCF in different organic solvents (mean ± RSD, n = 4).
Fig. 2. Effect of the derivatization reagent (MSTFA) volume on DCF recovery (mean ± RSD, n = 4).
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In this study, extraction solvents with lower (petroleum ether, n-hexane, isooctane, diethyl-
ether, cyclohexane, 2-propanol, n-pentane, toluene, ethyl acetate) and higher density than 
water (carbon disulfide (CS2), 1,2-dichlorobenzene, dichloromethane, 1,2,4-trichloroben-
zene, chloroform, bromoform) were studied. After centrifugation, chloroform, CS2, 1,2-di-
chlorobenzene, 1,2,4-trichlorobenzene and bromoform appeared at the bottom of the tube 
while the other extraction solvents were not collected because of their high solubility in 
water. As seen in Fig. 1, the best recoveries were obtained with chloroform. In comparison 
with the other solvents used, chloroform had a lower dipole moment. The lower dipole mo-
ment  allowed better interaction between solvent molecules and DCF. Fig. 2 shows the effect 
of derivatization reagent volume, ranging from 25 to 200 µL, on extraction with MSTFA. As 
the MSTFA volume increased, the recovery values of DCF decreased. Therefore, 25 µL MST-
FA was selected as optimal. Extraction and derivatization were performed with the support 
of vortex agitation. It affected the extraction equilibrium between DCF and chloroform and 
the mass transfer process of the DCF. When the agitation speed was increased up to 3000 
rpm, extraction efficiency of DCF increased from 3 to 82 % (see Fig. 3).
Factorial experimental design
The extraction solvent volume, extraction and derivatization time and water ionic 
strength were simultaneously optimized using a 23 factorial design (24). The effect of each 
factor was evaluated using the analysis of variance (p-values at 5 % significance level). All 
factors were determined as significant factors. Factors 1 (solvent volume) and 2 (extraction 
and derivatization time) exhibited positive effects while factor 3 (ionic strength of the sam-
ple) had a negative effect. When the extraction solvent volume was increased from 100 to 
200 µL, DCF recovery increased from 82 to 93 % (see Fig. 4). The number of submicron 
droplets increased with increasing the volume of chloroform. Thus, the solvent and water 
Fig. 3. Effect of vortex agitation speed on DCF recovery (mean ± RSD, n = 4).
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contact surface increased and higher extraction efficiency was obtained. When the extrac-
tion time and derivatization time were increased from 2 to 5 min, the recovery of DCF 
increased from 93 to 98 %. It was observed that higher mass transfer from the aqueous 
phase to solvent phase was achieved with the increase in extraction time. When NaCl 
concentration in the water sample increased from 0 to 0.05 g mL–1, the extraction of DCF 
decreased from 82 to 51 %. Because of the increasing ionic strength of the sample, the mass-
transfer process and extraction efficiency decreased. The interaction between factors 1 and 
2 was determined as significant with a positive effect. Interactions between factors 1 and 
3 and factors 2 and 3 were found to be significant factors with a negative effect. The opti-
mum conditions for VALLME and derivatization of DCF from the water sample were 
found as: 5 mL aqueous sample, 200 µL chloroform, 25 µL MSTFA, extraction and deri-
vatization time 5 min at 3000 rpm, centrifugation 5 min at 4000 rpm with no addition of 
NaCl.
Analytical performances of the optimized method
Analytical performances of the method were evaluated through limits of detection 
(LOD) and quantification (LOQ), correlation coefficient (R2), repeatability and extraction 
recovery. Method validation was carried out according to the official document (25). LOD 
and LOQ were calculated at a signal-to-noise ratio (S/N) of 3 and 10, resp. (26). LOD and 
LOQ were determined as 0.002 and 0.007 µg L–1. R2 value for the calibration line drawn at 
seven concentrations points in the concentration range of 0.001–10 µg L–1 of DCF was 
0.9998. RSD below 1.20 % was obtained from six injections of 0.1 µg L–1 of DCF. The opti-
mized VALLME in situ derivatization was applied to distilled water spiked with DCF. 
Recoveries obtained for fortifications of 0.1, 1.0 and 5.0 µg L–1 DCF were 99.3, 101.1 and 98.5 
Fig. 4. Effects of the factorial experimental design factors used in VALLME with the in situ derivatiza-
tion procedure (see Table I) on DCF recovery (mean, n = 2).
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%, resp. When statistical evaluations were carried out between spike levels 0.1–1.0, 0.1–5.0 
and 1.0–5.0 µg L–1, no significant differences (p < 0.05) were observed.
Real water samples including tap, surface and bottled water, domestic wastewater and 
treated domestic wastewater were fortified with 1 µg L–1 of DCF and the optimized 
VALLME in situ derivatization and traditional SPE method were performed. Blank analy-
sis was also carried out with distilled water to be sure that no interfering compounds were 
present. Tap water, bottled water, surface water and effluent water samples were free of 
DCF contamination. However, DCF was present in influent water samples at a concentra-
tion of 35.8 ng L–1. The obtained results are given in Table II. As seen in Table II, sample 
matrix did not adversely affect the efficiency of the VALLME in situ derivatization proce-
dure. The results also showed that the efficiency of the optimized method was higher than 
that of the SPE method.
Comparison of the proposed method with other methods
Performance of the proposed method was compared with the other, previously re-
ported extraction methods for DCF determination in water samples (18, 27–33). The pro-
posed method brings several advantages. The RSD values and linearity range of the pro-
posed method are comparable with different extraction techniques given in the literature 
(see Table III). LOD obtained with VALLME with in situ derivatization (GC-MS) is gener-
ally better than those obtained with MNPs-based dispersive-micro-SPE (HPLC-UV), US-
AEME with in situ derivatization (GC-MS), graphene oxide-based DSPE with in situ de-
rivatization (GC-MS), and SALLE with in situ derivatization (GC-MS). The extraction and 
derivatization time, sample and solvent volume of the optimized procedure are much 
lower than in the SPE derivatization (GC-MS) method. The proposed method has shown 
to be comparable with USAEME with in situ derivatization (GC-MS) in regard to extraction 
efficiency. The extraction recovery of the method is generally higher than in other methods 
given in Table III. The new method also reduces solvent waste and does not require any 
additional equipment for derivatization.
Table II. Comparison of the proposed method with the SPE method
DCF
Recovery (%)
VALLME in situ  
derivatization method
SPE method
Tap water 99.3 ± 5 88.4 ± 4
Bottled water  101.2 ± 6 87.5 ± 5
Surface water 98.4 ± 5 85.5 ± 6
Influent water 96.1 ± 6 85.1 ± 6
Effluent water 99.3 ± 4 80.2 ± 7
a DCF fortification: 1 µg L–1.
b Mean ± RSD, n = 4.
321
S. Aydin et al.: I Analysis of diclofenac in water samples using in situ derivatization-vortex-assisted liquid-liquid microextraction 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































S. Aydin et al.: I Analysis of diclofenac in water samples using in situ derivatization-vortex-assisted liquid-liquid microextraction 
with gas chromatography-mass spectrometry, Acta Pharm. 68 (2018) 313–324.
 
CONCLUSIONS
The paper presents a novel analytical method based on simultaneous VALLME and 
MSTFA derivatization combined with GC-MS for the determination of DCF in water and 
wastewater. Experimental parameters (extraction solvent type, the amount of derivatiza-
tion reagent, and vortex agitation speed) influencing the extraction process were initially 
optimized. Other critical variables involving the volume of extraction solvent, extraction 
and derivatization time, and ionic strength of the sample were optimized using a 23 facto-
rial experimental design. VALLME with the in situ derivatization-GC-MS method can be 
considered an emerging alternative to SPE. Lower organic solvent consumption decreases 
environmental pollution and waste treatment costs.
The method was intended for determination of DCF residues in real water samples 
such as tap, bottled and surface water and also influent and effluent samples taken from 
Konya domestic WWTP.
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